Literature DB >> 6617078

Theobromine kinetics and metabolic disposition.

S M Tarka, M J Arnaud, B H Dvorchik, E S Vesell.   

Abstract

Metabolism and kinetics of a single oral dose of 30 microCi 8-14C-theobromine with 10 mg/kg theobromine sodium acetate were studied in six healthy, nonmedicated, nonsmoking men after 14 days' abstention from all methylxanthine sources. Identification and quantitation of metabolites in plasma and urine both by HPLC and by thin-layer chromatography coupled with radiography indicated that theobromine was predominant in plasma. For urine, both methods identified theobromine as well as 7-methylxanthine, 7-methyluric acid, 3-methylxanthine, 6-amino-5[N-methylformylamino]-1-methyluracil, and a small amount of 3,7-dimethyluric acid as the metabolites of theobromine. All administered radioactivity was recovered in urine and no polar metabolites could be detected. Analysis of the urinary excretion data by the sigma-minus method allowed calculation of the apparent first-order rate constants for production of 7-methylxanthine, 7-methyluric acid, 3-methylxanthine, 3,7-dimethyluric acid, and 6-amino-5[N-methylformylamino]-1-methyluracil.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6617078     DOI: 10.1038/clpt.1983.212

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  Reinforcing effects of caffeine and theobromine as found in chocolate.

Authors:  Hendrik J Smit; Rachel J Blackburn
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

2.  Effect of theobromine on dissolution of uric acid kidney stones.

Authors:  Francesca Julià; Antonia Costa-Bauza; Francisco Berga; Felix Grases
Journal:  World J Urol       Date:  2022-06-11       Impact factor: 3.661

Review 3.  Recent advances in caffeine and theobromine toxicities: a review.

Authors:  M U Eteng; E U Eyong; E O Akpanyung; M A Agiang; C Y Aremu
Journal:  Plant Foods Hum Nutr       Date:  1997       Impact factor: 3.921

4.  Urinary caffeine metabolites in man. Age-dependent changes and pattern in various clinical situations.

Authors:  D Ullrich; D Compagnone; B Münch; A Brandes; H Hille; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

5.  Pharmacokinetics of theobromine and its metabolites in rabbits.

Authors:  G L Traina; M Bonati
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

6.  Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.

Authors:  A Lelo; D J Birkett; R A Robson; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

7.  The relevance of theobromine for the beneficial effects of cocoa consumption.

Authors:  Eva Martínez-Pinilla; Ainhoa Oñatibia-Astibia; Rafael Franco
Journal:  Front Pharmacol       Date:  2015-02-20       Impact factor: 5.810

Review 8.  Caffeine: cognitive and physical performance enhancer or psychoactive drug?

Authors:  Simone Cappelletti; Daria Piacentino; Piacentino Daria; Gabriele Sani; Mariarosaria Aromatario
Journal:  Curr Neuropharmacol       Date:  2015-01       Impact factor: 7.363

9.  Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis.

Authors:  Felix Grases; Adrian Rodriguez; Antonia Costa-Bauza
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

10.  Effect of Consumption of Cocoa-Derived Products on Uric Acid Crystallization in Urine of Healthy Volunteers.

Authors:  Antonia Costa-Bauza; Felix Grases; Paula Calvó; Adrian Rodriguez; Rafael M Prieto
Journal:  Nutrients       Date:  2018-10-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.